MoneyWorks4Me

The sales slipped to Rs. 132.98 millions for the March 2025 quarter as against Rs. 147.22 millions during the year-ago period.The Company's Net profit for the March 2025 quarter have declined marginally to Rs. 10.41  millions as against Rs. 11.46 millions reported during the corresponding quarter ended.A decline of 28.05 millions was observed in the OP in the quarter ended March 2025 from 29.49 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 132.98 147.22 -9.67 559.79 558.83 0.17 559.79 558.83 0.17
Other Income -1.95 4.20 -146.43 1.76 3.75 -53.07 1.76 3.75 -53.07
PBIDT 28.05 29.49 -4.88 91.40 83.22 9.83 91.40 83.22 9.83
Interest 4.77 5.30 -10.00 20.66 21.49 -3.86 20.66 21.49 -3.86
PBDT 23.28 24.19 -3.76 70.74 61.73 14.60 70.74 61.73 14.60
Depreciation 9.06 8.91 1.68 35.60 35.65 -0.14 35.60 35.65 -0.14
PBT 14.22 15.28 -6.94 35.14 26.08 34.74 35.14 26.08 34.74
TAX 3.81 3.82 -0.26 9.04 6.52 38.65 9.04 6.52 38.65
Deferred Tax -5.33 0.61 -973.77 -4.55 1.99 -328.64 -4.55 1.99 -328.64
PAT 10.41 11.46 -9.16 26.10 19.56 33.44 26.10 19.56 33.44
Equity 54.85 54.85 0.00 54.85 54.85 0.00 54.85 54.85 0.00
PBIDTM(%) 21.09 20.03 5.30 16.33 14.89 9.64 16.33 14.89 9.64
Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1224.50
Cipla 1337.00
Lupin 1925.00
Zydus Lifesciences 1127.85
View more..